Cardiff Oncology | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Trial results

27 September 2023

Another twist in Cardiff’s onvansertib plan

Front-line phase 3 plans take shape, as the company claims a new success, this time in pancreatic cancer.

Trial results

7 August 2023

Cardiff Oncology doubles down on onvansertib

Subscribe to Cardiff Oncology